Hinge Health Inc.

HNGE | NYSE

Price Alert Chart Builder DCF Calculator

$94.45

-$0.45 (-0.47%)

At close: Sep 21, 2026, 4:00 PM ET

$94.85

+$0.40 (+0.42%)

Pre-market: Sep 22, 2026, 4:23 AM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Market Data

Market Cap $7.34B

Enterprise Value $6.93B

Beta 1.36

Average Volume 1.94M

Shares Outstanding (Diluted) 82.34M

Shares Change YoY 5.55%

Institutional Ownership 71.45%

Exchange NYSE

ISIN US4333131039

Price Performance

Price Change 1M 6.3%

Price Change 3M 34.2%

Price Change 6M 135.0%

Price Change YTD 107.3%

Price Change 1Y 63.3%

Price Change 3Y 135.2%

Price Change 5Y 135.2%

1M CAGR (ann.) 18.5%

1Y CAGR (ann.) 67.3%

5Y CAGR (ann.) N/A

All-Time CAGR 101.2%

Valuation

PE Ratio 73.22

Forward PE 30.24

PEG Ratio 0.93

Forward PEG 2.69

PS Ratio 10.15

Forward PS 6.70

PB Ratio 21.23

P/FCF Ratio 25.44

P/Adj. FCF Ratio 35.73

P/OCF Ratio 25.60

EV/Sales 9.62

EV/EBIT 70.04

EV/EBITDA 67.30

EV/FCF 24.10

Earnings Yield 1.4%

FCF Yield 3.9%

Adj. FCF Yield 2.8%

Financial Health

Net Cash $389.39M

Total Debt $5.89M

Cash & Short-Term Investments $389.39M

Total Assets $827.4M

Current Ratio 1.34

Quick Ratio 1.30

Debt / Equity Ratio 0.02

Debt / EBITDA 0.06

Debt / FCF 0.02

OCF / Debt 49.41

Interest Coverage 0.00

Altman Z-Score 8.98

Piotroski F-Score 6

Margins & Profitability

Gross Profit Margin 84.5%

Operating Profit Margin 13.0%

EBITDA Margin 14.3%

Net Profit Margin 15.2%

FCF Margin 39.9%

Adj. FCF Margin 28.4%

SBC / Revenue 11.5%

SBC Impact (per share) -28.8%

Returns

Return on Assets 13.2%

Return on Equity 30.3%

Return on Invested Capital 26.3%

Return on Capital Employed 27.1%

Return on Tangible Assets 14.3%

Historical Growth (CAGR)

Revenue CAGR 3Y 117.7%

Revenue CAGR 5Y N/A

Revenue CAGR 10Y N/A

EPS CAGR 3Y 66.2%

EPS CAGR 5Y N/A

EPS CAGR 10Y N/A

FCF CAGR 3Y N/A

FCF CAGR 5Y N/A

FCF CAGR 10Y N/A

Analyst Forecasts

Analyst Rating Buy

Analyst Count 16

EPS Growth Next 3Y 47.8%

Revenue Growth Next 3Y 32.5%

Earnings Date N/A

EPS Estimate (next Q) N/A

EPS Growth Est (next Q) N/A

Revenue Est (next Q) N/A

Revenue Growth Est (next Q) N/A

Fair Value Estimates

Graham Number $11.26

Graham Upside -88.1%

Lynch Fair Value N/A

Lynch Upside N/A

Price Target $98.92

Price Target Upside 4.7%

Cash Flow

Operating Cash Flow $290.79M

Free Cash Flow $287.33M

Adj. Free Cash Flow $204.52M

FCF Per Share $3.65

OCF Per Share $3.69

OCF/S Ratio 40.4%

Income Statement

Revenue $720.06M

Gross Profit $608.59M

Operating Income $93.67M

EBITDA $102.89M

Net Income $109.07M

EPS (Diluted) $1.29

Revenue / Employee $501.09K

Profit / Employee $75.9K

Employees 1,437